Loading
Total declarations
Company
▲ Purchases (1 ops.)
▼ Sales (0 ops.)
Latest filing published 04 Oct 2024 for Augmedix, Inc., €43k. Read the official filing
Filing timeline
BuySaleSandra Breber
Insider track record
Disclosed buys
1
Disclosed sells
0
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Sandra Breber: trading record in brief
All filings by Sandra Breber on record concern Augmedix, Inc., in the capacity of chief executive. Between 28 October 2021 and 2 October 2024, the trades on record add up to 4 filings.
No open-market sale appears; the market trades are 1 purchase worth €43k. Open-market purchases are the filings investors watch most closely, because the insider pays for the shares out of pocket. Besides market trades, the filings include 2 option exercises.
The latest filing, published on 4 October 2024, reports a transaction of €43k in Augmedix, Inc. The latest purchase dates back some time: it was published 1,812 days ago, on 1 November 2021. Typically, a trade is published a median of 3 days after it takes place. The legal deadline for a Form 4 is two business days after the transaction. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Companies and markets linked to Sandra Breber
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations4 total
20,295 shares@ US$2.35100.0% of flowCommon StockSEC:0001213900-24-085366:0
6,250 sharesCommon StockSEC:0001213900-24-070867:0
6,250 sharesCommon StockSEC:0001213900-24-044876:0
12,500 shares@ US$4.00100.0% of flowCommon StockSEC:0001213900-21-055926:0
Canonical exit: 26 Jan 2022 (T+90)
4 of 4 declarations
